Negative impact of non-evidence-based information received by women taking antidepressants during pregnancy from health care providers and others
- PMID: 22260766
- DOI: 10.1016/S1701-2163(16)35136-2
Negative impact of non-evidence-based information received by women taking antidepressants during pregnancy from health care providers and others
Abstract
Objectives: The use of antidepressants by women during pregnancy continues to be a controversial subject, with conflicting information regarding the safety of this group of drugs. We sought (1) to determine the impact of information, advice, and comments women received from health care providers, family, and media about use of antidepressants during pregnancy, and (2) to compare experiences regarding the psychosocial impact of women who continued and discontinued antidepressant therapy during pregnancy.
Methods: Women who had taken an antidepressant at some point during pregnancy were interviewed. The responses of women who continued antidepressant therapy throughout pregnancy were compared with those of women who discontinued therapy at some point in the pregnancy. A questionnaire with questions pertaining to information women had received from various individuals regarding the use of an antidepressant while pregnant was administered to both groups.
Results: Ninety-four interviews were completed; 78 were with women who continued antidepressant therapy throughout pregnancy, and 16 were with women who discontinued therapy. The small number of women in the discontinuation group was a result of many women declining to participate. More than one half of the women who continued the medication throughout pregnancy had frequently considered discontinuing, despite reassurance that continuation would cause no harm to their baby. Negative information was recalled far more often than reassuring information.
Conclusion: Information from friends, family, and health care providers can have a negative impact on decision-making regarding pharmacotherapy for depression during pregnancy. Health care providers should be cognizant of this when counselling patients who require antidepressant therapy during pregnancy.
Similar articles
-
Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making.Arch Womens Ment Health. 2005 Nov;8(4):214-20. doi: 10.1007/s00737-005-0094-8. Epub 2005 Jun 17. Arch Womens Ment Health. 2005. PMID: 15959622
-
Longitudinal study of depression, anxiety, irritability, and stress in pregnancy following evidence-based counseling on the use of antidepressants.J Psychiatr Pract. 2007 Jan;13(1):33-9. doi: 10.1097/00131746-200701000-00005. J Psychiatr Pract. 2007. PMID: 17242590
-
Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancy.Eur Neuropsychopharmacol. 2019 Jul;29(7):803-812. doi: 10.1016/j.euroneuro.2019.06.007. Epub 2019 Jun 24. Eur Neuropsychopharmacol. 2019. PMID: 31248651
-
Women's decision making about antidepressant use during pregnancy: A narrative review.Depress Anxiety. 2018 Dec;35(12):1158-1167. doi: 10.1002/da.22821. Epub 2018 Aug 12. Depress Anxiety. 2018. PMID: 30099817 Review.
-
Pharmacotherapy of depression in pregnancy.Ann Clin Psychiatry. 2004 Apr-Jun;16(2):87-100. doi: 10.1080/10401230490453662. Ann Clin Psychiatry. 2004. PMID: 15328902 Review.
Cited by
-
Antidepressant use during pregnancy: navigating the sea of information.Can Fam Physician. 2013 Sep;59(9):941, 943-4. Can Fam Physician. 2013. PMID: 24029507 Free PMC article.
-
Selective serotonin reuptake inhibitor discontinuation during pregnancy: at what risk?Can Fam Physician. 2014 Dec;60(12):1105-6. Can Fam Physician. 2014. PMID: 25642484 Free PMC article.
-
Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study.Neurology. 2013 Apr 23;80(17):1565-70. doi: 10.1212/WNL.0b013e31828f18c1. Epub 2013 Apr 3. Neurology. 2013. PMID: 23553472 Free PMC article. Clinical Trial.
-
Prescribing antidepressants and anxiolytic medications to pregnant women: comparing perception of risk of foetal teratogenicity between Australian Obstetricians and Gynaecologists, Speciality Trainees and upskilled General Practitioners.BMC Pregnancy Childbirth. 2020 Oct 14;20(1):618. doi: 10.1186/s12884-020-03293-0. BMC Pregnancy Childbirth. 2020. PMID: 33054795 Free PMC article. No abstract available.
-
Reproductive Decision-Making Capacity in Women With Psychiatric Illness: A Systematic Review.J Acad Consult Liaison Psychiatry. 2022 Jan-Feb;63(1):61-70. doi: 10.1016/j.jaclp.2021.08.007. Epub 2021 Aug 27. J Acad Consult Liaison Psychiatry. 2022. PMID: 34461294 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical